Single-Dose Euglycemic Clamp Study Demonstrating Pharmacokinetic and Pharmacodynamic Similarity Between SAR341402 Insulin Aspart and US- and EU-Approved Versions of Insulin Aspart in Subjects with Type 1 Diabetes

Background: The objective of this study was to demonstrate the pharmacokinetic and pharmacodynamic similarity among SAR341402 insulin aspart biosimilar/follow-on product, United States-sourced insulin aspart (NovoLog(®)), and European Union-sourced insulin aspart (NovoRapid(®)). Materials and Method...

Descripción completa

Detalles Bibliográficos
Autores principales: Kapitza, Christoph, Nosek, Leszek, Schmider, Wolfgang, Teichert, Lenore, Nowotny, Irene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104901/
https://www.ncbi.nlm.nih.gov/pubmed/31825248
http://dx.doi.org/10.1089/dia.2019.0351

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104901/
https://www.ncbi.nlm.nih.gov/pubmed/31825248
http://dx.doi.org/10.1089/dia.2019.0351

Ejemplares similares